194 related articles for article (PubMed ID: 22266706)
1. Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus.
You L; Wang Y; Jin Y; Qian W
Oncol Rep; 2012 Apr; 27(4):971-8. PubMed ID: 22266706
[TBL] [Abstract][Full Text] [Related]
2. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
Yoon AR; Kim JH; Lee YS; Kim H; Yoo JY; Sohn JH; Park BW; Yun CO
Hum Gene Ther; 2006 Apr; 17(4):379-90. PubMed ID: 16610926
[TBL] [Abstract][Full Text] [Related]
3. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
[TBL] [Abstract][Full Text] [Related]
4. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.
Meng HT; Li L; Liu H; Wang Y; Li GC; Qian WB
Acta Pharmacol Sin; 2009 Nov; 30(11):1529-36. PubMed ID: 19820719
[TBL] [Abstract][Full Text] [Related]
5. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
[TBL] [Abstract][Full Text] [Related]
6. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
7. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
[TBL] [Abstract][Full Text] [Related]
9. Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.
Xiao L; Li X; Niu N; Qian J; Xie G; Wang Y
Mol Cell Biochem; 2010 Jul; 340(1-2):31-40. PubMed ID: 20165905
[TBL] [Abstract][Full Text] [Related]
10. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites models of hepatocellular carcinoma.
Hsieh JL; Lee CH; Teo ML; Lin YJ; Huang YS; Wu CL; Shiau AL
Cancer Sci; 2009 Mar; 100(3):537-45. PubMed ID: 19134007
[TBL] [Abstract][Full Text] [Related]
12. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis.
Tolksdorf B; Zarif S; Eberle J; Hazini A; Dieringer B; Jönsson F; Kreppel F; Kurreck J; Fechner H
J Mol Med (Berl); 2021 Sep; 99(9):1279-1291. PubMed ID: 34028599
[TBL] [Abstract][Full Text] [Related]
14. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
15. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24.
Wu YM; Zhang KJ; Yue XT; Wang YQ; Yang Y; Li GC; Li N; Wang YG
Acta Pharmacol Sin; 2009 Apr; 30(4):467-77. PubMed ID: 19270721
[TBL] [Abstract][Full Text] [Related]
17. Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.
Sarkar S; Quinn BA; Shen XN; Dash R; Das SK; Emdad L; Klibanov AL; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Oncotarget; 2015 May; 6(13):10712-27. PubMed ID: 25926554
[TBL] [Abstract][Full Text] [Related]
18. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.
Kim J; Kim PH; Yoo JY; Yoon AR; Choi HJ; Seong J; Kim IW; Kim JH; Yun CO
Gene Ther; 2009 Sep; 16(9):1111-21. PubMed ID: 19494843
[TBL] [Abstract][Full Text] [Related]
19. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line.
Kamarajan P; Sun NK; Sun CL; Chao CC
FEBS Lett; 2001 Sep; 505(2):206-12. PubMed ID: 11566177
[TBL] [Abstract][Full Text] [Related]
20. Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.
Siervo-Sassi RR; Marrangoni AM; Feng X; Naoumova N; Winans M; Edwards RP; Lokshin A
Cancer Lett; 2003 Feb; 190(1):61-72. PubMed ID: 12536078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
